Genetic identification and molecular modeling characterization of a novel POU3F4 variant in two Italian deaf brothers.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 22 07 2019
revised: 18 11 2019
accepted: 19 11 2019
pubmed: 2 12 2019
medline: 5 6 2020
entrez: 2 12 2019
Statut: ppublish

Résumé

In this report, we describe a novel, probably pathogenic hemizygous variant c.870G > T (p.Lys290Asn) in the POU3F4 gene in two deaf brothers from one Italian family with identical inner ear abnormalities specific to X-linked deafness-2 (DFNX2). In addition, we performed homology modeling to predict the effect of the missense variant on the protein structure showing a possible disruption of the normal folding. The identification of pathogenic variants causing X-linked recessive deafness will improve molecular diagnosis, genetic counseling, and knowledge of the molecular epidemiology of hearing loss among Italian individuals. Taken together, we recommend preoperative gene mutation analysis in patients who have DFNX2 diagnosed on the basis of characteristic radiological findings, in order to provide with better prognostic information, the risk of recurrence, and improved rehabilitation options. Finally, the present work strengthens the hypothesis that DFNX-2 could be considered as a syndromic deafness, since mixed hearing loss is associated with other dysfunctions of the neuropsychological profile of the patients.

Identifiants

pubmed: 31786483
pii: S0165-5876(19)30543-9
doi: 10.1016/j.ijporl.2019.109790
pii:
doi:

Substances chimiques

POU Domain Factors 0
POU3F4 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109790

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Sara Giannantonio (S)

Audiology and Otosurgery Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy. Electronic address: sara.giannantonio@opbg.net.

Emanuele Agolini (E)

Genetics Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy.

Alessandro Scorpecci (A)

Audiology and Otosurgery Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy.

Roberta Anzivino (R)

Audiology and Otosurgery Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy.

Emanuele Bellacchio (E)

Genetics Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy.

Dario Cocciadiferro (D)

Genetics Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy.

Antonio Novelli (A)

Genetics Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy.

Maria Cristina Digilio (MC)

Genetics Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy.

Pasquale Marsella (P)

Audiology and Otosurgery Unit, "Bambino Gesù" Pediatric Hospital, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH